Mini Dock Rapid Molecular POCT System – VET

Description

Unmatched Precision and Speed

The Pluslife Mini Dock excels in delivering test results significantly faster than conventional antigen tests. By concluding results within 15 to 35 minutes, this system offers a diagnostic edge, detecting COVID-19 up to two days earlier. It boasts a remarkable 98.91% sensitivity and 99.58% specificity, ensuring reliable and precise detection of SARS-CoV-2 with minimal false negatives and positives.

Innovative RHAM Technology

The core of the Mini Dock is the RHAM technology, a self-developed isothermal amplification molecular detection method. Unlike traditional methods that require multiple steps and longer time frames, RHAM performs isothermal amplification and signal release simultaneously. Enhanced with high-performance enzymes and ingenious specificity-enhancing steps, RHAM technology delivers ultra-sensitive, accurate results comparable to qPCR tests but far superior to traditional isothermal amplification techniques such as LAMP.

Versatility and User-Friendly Design

Operational Simplicity

The Pluslife Mini Dock is designed for ease of use, featuring a simple 5-step procedure: Sampling, Pouring, Mixing, Testing, and Result Recording. Its portability, lightweight design (210g), and compatibility with computer software and mobile apps make it suitable for varied testing environments.

Specifications

• Dimensions: 101 x 91 x 65 mm
• Weight: 210 g
• Operating Temperature: 15°C–30°C
• Operating Humidity: ≤80%
• Sample Type: Nasal swab
• Limit of Detection (LoD): 400 copies/mL
• Turnaround Time (TAT): 15–35 mins
• Shelf Life: 13 months at room temperature

Clinical Validation

Clinically proven to match the accuracy of RT-PCR nucleic acid detection, the Mini Dock has undergone rigorous comparative studies. These studies demonstrate its consistent capability to detect low viral loads, ensuring early and reliable COVID-19 detection even in asymptomatic cases. This high sensitivity is especially critical in identifying and isolating infected individuals to prevent further spread.

Comparative Advantage

Compared to antigen tests, which often miss low-concentration viral infections, the Pluslife Mini Dock provides a clear advantage:

• Virus Load Detection: Consistently detects specimens with as low as 400 copies/mL of SARS-CoV-2.
• Advanced Warning: Identifies infections nearly two days before antigen tests can.
• High Sensitivity and Specificity: Outperforms most antigen tests, which fail to detect samples with Ct values greater than 30.

Application and Flexibility

The Pluslife Mini Dock is versatile and expandable, capable of adapting to detect multiple COVID-19 variants and potentially other pathogens. Its comprehensive application in various settings, including clinical laboratories, point-of-care testing, and remote locations, makes it an indispensable tool in the fight against COVID-19.

The Pluslife Mini Dock is a game-changer in the realm of COVID-19 diagnostics, offering rapid, accurate, and reliable testing solutions to safeguard public health and prevent viral transmission.